Prevention Genetics LogoExact Sciences is now Abbott
Test Code 10625
New York approved

Congenital Disorders of Glycosylation (CDG) Panel

54 genes

2 - 3 weeks (6 - 12 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of a Congenital Disorder of Glycosylation (CDG)
  • Individuals with abnormal serum transferrin isoform results
  • Individuals with abnormal glycosylation results on cellular biomarkers
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

OTHER OPTIONS
for standard institutional pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Let us connect you with our specialists that will assist you with anything from understanding products to navigating insurance questions.